Evidence map›Paper›PMID 39624423›Full record

ArticleBioactive materials2025

Biomimetic fabricated tubular graft

Shiwei Niu, Fan Li, Zhi Lin, Bo Chen, Lechun Lyu, Yongliang Jiang, Wanting Li, Jianlin Jiao, Yi Han, Di Lu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioactive materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Biomimetic materials for medical applications.Chinese medical journal · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shiwei NiuYunnan Key Laboratory of Stem Cell and Regenerative Medicine, College of Rehabilitation, Kunming Medical University, Kunming, 650500, PR China.
Fan LiYunnan Key Laboratory of Stem Cell and Regenerative Medicine, College of Rehabilitation, Kunming Medical University, Kunming, 650500, PR China.
Zhi LinDepartment of Cardiology, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650101, PR China.
Bo ChenYunnan Key Laboratory of Stem Cell and Regenerative Medicine, College of Rehabilitation, Kunming Medical University, Kunming, 650500, PR China.
Lechun LyuYunnan Key Laboratory of Stem Cell and Regenerative Medicine, College of Rehabilitation, Kunming Medical University, Kunming, 650500, PR China.
Yongliang JiangYunnan Key Laboratory of Stem Cell and Regenerative Medicine, College of Rehabilitation, Kunming Medical University, Kunming, 650500, PR China.
Wanting LiYunnan Key Laboratory of Stem Cell and Regenerative Medicine, College of Rehabilitation, Kunming Medical University, Kunming, 650500, PR China.
Jianlin JiaoYunnan Key Laboratory of Stem Cell and Regenerative Medicine, College of Rehabilitation, Kunming Medical University, Kunming, 650500, PR China.
Yi HanYunnan Key Laboratory of Stem Cell and Regenerative Medicine, College of Rehabilitation, Kunming Medical University, Kunming, 650500, PR China.
Di LuYunnan Key Laboratory of Stem Cell and Regenerative Medicine, College of Rehabilitation, Kunming Medical University, Kunming, 650500, PR China.
Lin SunDepartment of Cardiology, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650101, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since inferior biomimetic fabrication and anti-thrombosis process always lead to the implantation failure of artificial vascular grafts, the development of bioactive platform which can promote endothelialization is fundamental in the research for blood vessel substitutes to overcome the low-efficiency or hyperplasia. To solve the limitation of insufficient autologous sources of small blood vessels, this study prepared a tri-layer small diameter vascular based on citrate, followed by covalently immobilizing of specific peptides to achieve

Indexed as

BiomimeticGastrodin coatingHierarical cell recruitmentPeptidesVascular graft

Identifiers

PMID39624423
PMCPMC11609477

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.